screening of advanced glycation end-products (age) inhibitory activity of extracts from gymnema...
TRANSCRIPT
-
7/30/2019 Screening of Advanced Glycation End-Products (AGE) Inhibitory Activity of Extracts from Gymnema Sylvestre and Costus Spiralis
1/13
Screeningofadvancedglycation
endproducts
(AGE)
inhibitory
activity
ofextracts fromGymnema sylvestre
andCostus spiralis
Ivette Sierra
Vernica Aponte
Dra.Jannette
Gavilln
Surez
-
7/30/2019 Screening of Advanced Glycation End-Products (AGE) Inhibitory Activity of Extracts from Gymnema Sylvestre and Costus Spiralis
2/13
Maillard reaction
Thisreactionoccurinthehumanbodyandisdividedin
twostages:
Theearlyandreversiblestageistheformationof
Amadori compoundsandSchiffbase.
Thelateandirreversiblestageistheformationof
fluorescentproteinscontainingadvancedglycation end
products(AGE)
Protein+Sugar Schiff Amadori AdvancedGlycation
Base Products EndProducts(AGE)
-
7/30/2019 Screening of Advanced Glycation End-Products (AGE) Inhibitory Activity of Extracts from Gymnema Sylvestre and Costus Spiralis
3/13
Advancedglycation endproducts
(AGE) Areaheterogeneous group of molecules formed from the nonenzymatic
reaction of reducing sugars with freeaminogroups of proteins.
Fluorescentcomplexformedofasugarandaprotein.
Have the ability for covalent crosslink formation between proteins,which
alters their structure and function.
e.g.pentosidine
Ayra,Diaz,1999
-
7/30/2019 Screening of Advanced Glycation End-Products (AGE) Inhibitory Activity of Extracts from Gymnema Sylvestre and Costus Spiralis
4/13
DiabetesandAGEinhibition
AccumulationofAGEisonecauseofdiabetescomplicationssuch
cataracts,impairedwoundhealing,vasculardamageandarterialwall
stiffening.
10.6%ofPuertoRicanpopulationsuffersdiabetes.
Aminoguanidine havebeenreportedasinhibitoroftheMaillard reaction
buttheeffectivedoseisdangeroustothehumanbody.
Plantsand
natural
products
such
quercetin,
aspirin,
vitamin
B
represent
analternativetreatmenttopeoplewithdiabetes.
http://www.salud.gov.pr/Publicaciones/Articulos/Pages/EpidemiologiadelaDiabetes.aspx
-
7/30/2019 Screening of Advanced Glycation End-Products (AGE) Inhibitory Activity of Extracts from Gymnema Sylvestre and Costus Spiralis
5/13
Gymnema sylvestre
TheadministrationofGymnema
sylvestre forthe
treatment
of
diabeteshasbeensupportedby
experimentalresearchfindings.
Stimulatesinsulinreleaseand
regeneratespancreaticbetacells.
Leach,2007
-
7/30/2019 Screening of Advanced Glycation End-Products (AGE) Inhibitory Activity of Extracts from Gymnema Sylvestre and Costus Spiralis
6/13
Costus spiralis
Is widely used intraditional
medicineof Puerto
Rico
to treat
various diseases including
diabetes.
Da.MarianaCruzVzquez,
Cidra:Elt delas hojas deinsulina baja elazcar.
M.Benedetti,1996
-
7/30/2019 Screening of Advanced Glycation End-Products (AGE) Inhibitory Activity of Extracts from Gymnema Sylvestre and Costus Spiralis
7/13
Hypothesis
Gymnena sylvestre andCostus spiralis methanolicextractsinhibitAGE
formation.
Specificaims
TodeterminethepercentofAGEinhibitionofGymnena sylvestre and
Costus spiralis methanolicextracts.
Tocompare
the
percent
of
AGE
inhibition
of
Gymnena sylvestre and
Costus spiralis methanolicextractswithAminoguanidine.
-
7/30/2019 Screening of Advanced Glycation End-Products (AGE) Inhibitory Activity of Extracts from Gymnema Sylvestre and Costus Spiralis
8/13
Methodology
Invitro glycation Invitroglycation under
hyperglycemiaconditions.
Samplesincubatedat60C
SamplesAnalysis Samplesanalyzedbyspectroscopy
EX 350
nm;
EM
450
nm
DataAnalysisInhibition
percent
=Fluorescence
Intensity
(FI)
Control
FI
Test
x100
FIControl
-
7/30/2019 Screening of Advanced Glycation End-Products (AGE) Inhibitory Activity of Extracts from Gymnema Sylvestre and Costus Spiralis
9/13
Results
Inhibitionpercentat30h
68 %
43 %
14 %
0 10 20 30 40 50 60 70 80
%inhibition
G.sylvestre(20mg/mL)C.spiralis(20mg/mL)
Aminoguanidine(10mM;0.62mg/mL)
-
7/30/2019 Screening of Advanced Glycation End-Products (AGE) Inhibitory Activity of Extracts from Gymnema Sylvestre and Costus Spiralis
10/13
Conclusion
ThedecreasingorderofAGEinhibitionwas:
Aminoguanidine >C.spiralis >G.sylvestre Theresultssuggestthattheantidiabetes activityofGymnema
sylvestre isnotrelatedtoAGEinhibition.
Thehypothesiswasproven.
-
7/30/2019 Screening of Advanced Glycation End-Products (AGE) Inhibitory Activity of Extracts from Gymnema Sylvestre and Costus Spiralis
11/13
Futurework
UseotherconcentrationsofCostus spiralis tocalculateIC50
.
StudyinhibitoryactivityofaqueousextractsofGymnema
sylvestre andCostus spiralis.
-
7/30/2019 Screening of Advanced Glycation End-Products (AGE) Inhibitory Activity of Extracts from Gymnema Sylvestre and Costus Spiralis
12/13
References
Ayra M.,DiazO.,1999,Productos delaglucosilacion avanzada ydiabetesmellitus,RevCubana End,10,5764
LeachM.,2007, Gymnema sylvestre forDiabetesMellitus:ASystematicReview,J.Alt.Medicine,9,pp.977983
Matsuura,N.,
Aradate,
T.,
Sasaki,
C.,
Kojima,
H.,
Ohara,
M.,
Hasegawa,
J.,
Ubukata,M.,2002,ScreeningsystemfortheMaillard reactioninhibitorfromnaturalproductsextracts.J.HealthSci.48,520526
Wirasathien L.,Pengsuparp T.,
Suttisri R.,
Ueda
H.,
Moriyasu M.,
Kawanishi K.,
2007,Inhibitorsofaldose reductase andadvancedglycation endproductsformationfromleavesofStelechocarpus cauliflorus,Phytomedicine,14,546550
-
7/30/2019 Screening of Advanced Glycation End-Products (AGE) Inhibitory Activity of Extracts from Gymnema Sylvestre and Costus Spiralis
13/13
Screeningofadvancedglycation
endproducts
(AGE)
inhibitory
activity
ofextracts fromGymnema sylvestre
andCostus spiralis
Ivette Sierra
Vernica Aponte
Dra.Jannette
Gavilln
Surez